With support from afib.no, the researchers in The Norwegian Exercise and Atrial Fibrillation Initiative NEXAF, met for the first NEXAF workshop in Oslo earlier this month. Researchers from all the three NEXAF-studies, and from the research institutions The Arctic University… Read More ›
MD Laura K. Andreasen defended her PhD entitled “Genome-wide association studies of the left atrium and supraventricular tachycardias” the 18th of February 2022. The thesis includes three genome-wide association studies on 1) the left atrium assessed with cardiac magnetic resonance… Read More ›
The OMEMI (Omega-3 Fatty acids in Elderly with Myocardial Infarction) trial was performed by several members of the afib.no network. In the trial, elderly patients with a recent myocardial infarction were randomized to 1.8 g/day of n-3 polyunsaturated fatty acids… Read More ›
Edvard Liljedahl Sandberg: The primary aim of this study was to evaluate the diagnostic accuracy and usability of ECG247 Smart Heart Sensor compared to conventional Holter monitoring. Patients > 18 years of age referred for out-of-hospital long-term ECG recording regardless of… Read More ›
In this study we looked at clinical outcomes of patients who underwent cardioversion in the non-interventional Global Anticoagulant Registry in the FIELD-AF (GARFIELD-AF). 44 201 patients were included in an analysis comparing patients who received a baseline cardioversion with those… Read More ›
Thank you all for tuning in to this year’s afib.no meeting! We were thrilled to see so many of you there and impressed by the quality of the presentations. Day 1 started with the team behind the NEXAF study, who… Read More ›
Network members Eivind Sørensen (The Birkebeiner II Study), Turid Apelland, André La Gerche and Marius Myrstad (The NEXAF Detraining Study) attended the Pro@Heart Symposium in Leuven, Belgium September 24-26 2021. “Protecting the athlete by improving our understanding of athlete’s physiology”… Read More ›
High persistence and adherence among NOAC users Adequate persistence and adherence with non-vitamin K antagonists (NOACs) is essential for optimal stroke prevention in atrial fibrillation (AF), but large-scale studies comparing the different NOACs has been lacking. In a study recently… Read More ›
More than 50 researchers from Norway, Sweden, Denmark, Germany, The Netherlands, UK and Canada connected for a workshop on Atrial Remodeling in AF on Thursday April 15. The meeting started with one of the keynote speakers, dr. Pyotr Platonov who… Read More ›
Our colleague Rikke Buhl in Copenhagen, Denmark, has a new, exciting project on paroxysmal AF in horses. She would appreciate our help in collecting used implantable loop recorders (ILRs) from Medtronic (Reveal Linq) for use in trotter horses. They aim… Read More ›
afib.no 